Back to Journals » Biologics: Targets and Therapy » Volume 3

Anti-interleukin-2 receptor antibodies—basiliximab and daclizumab—for the prevention of acute rejection in renal transplantation

Total article views   HTML views PDF downloads Totals
12,805 Dovepress* 12,805+ 2,479 15,284
Totals 12,805 2,479 15,284
*Since 17 June 2009
+Since July 2016

View citations on Google Scholar